Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Retained Earnings (2016 - 2025)

Neuroone Medical Technologies' Retained Earnings history spans 14 years, with the latest figure at -$80.0 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 9.26% year-over-year to -$80.0 million; the TTM value through Dec 2025 reached -$80.0 million, down 9.26%, while the annual FY2025 figure was -$78.6 million, 4.81% down from the prior year.
  • Retained Earnings reached -$80.0 million in Q4 2025 per NMTC's latest filing, down from -$78.6 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$35.2 million in Q1 2021 to a low of -$80.0 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$60.1 million, with a median of -$61.1 million recorded in 2023.
  • Peak YoY movement for Retained Earnings: tumbled 32.88% in 2021, then dropped 4.81% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$43.6 million in 2021, then fell by 20.45% to -$52.6 million in 2022, then fell by 25.63% to -$66.0 million in 2023, then dropped by 10.89% to -$73.2 million in 2024, then dropped by 9.26% to -$80.0 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Retained Earnings are -$80.0 million (Q4 2025), -$78.6 million (Q3 2025), and -$77.0 million (Q2 2025).